Strata Critical Medical, Inc. Class A Common Stock SRTA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.15M— | —— | $57.42M+1,634% | -$3.74M-7.2% | -$3.49M+64.3% | ||
| $3.06M+1.7% | $3.01M+76.5% | $1.7M-4.1% | $1.78M+4.7% | $1.7M+10.9% | ||
| $5.04M-23.5% | $6.59M+292% | $1.68M-68.6% | $5.35M+26.8% | $4.22M-6.8% | ||
| -$77K— | —— | $554K+2,538% | $21K+224% | -$17K+83.8% | ||
| -$344K— | —— | —— | —— | $0— | ||
| -$149K-104% | $3.48M+96.3% | $1.77M-71.6% | $6.26M+1,103% | $520K— | ||
| -$2.16M— | —— | $7.48M+134% | $3.19M+240% | -$2.28M-113,800% | ||
| -$78K— | $0+100% | -$592K-870% | -$61K-369% | -$13K-102% | ||
| $27K-67.5% | $83K-75.9% | $345K— | —— | $93K-60.6% | ||
| -$3K— | —— | —— | $999K-22.7% | $1.29M— | ||
| $3.89M+147% | -$8.31M+77.7% | -$37.3M-1,117% | -$3.06M-1,146% | -$246K+86.0% | ||
| $5.18M+180% | $1.85M-34.7% | $2.83M+22.8% | $2.3M-11.9% | $2.61M-42.9% | ||
| $30.5M— | —— | —— | $43.55M-59.6% | $107.75M— | ||
| $302K+92.4% | $157K-47.1% | $297K-30.8% | $429K-19.4% | $532K+15.9% | ||
| $0— | $0-100% | $49.86M+308% | $12.21M-85.5% | $84.2M+17,118% | ||
| $24.73M+35.4% | $18.27M+662% | $2.4M-91.6% | $28.68M+40.5% | $20.41M— | ||
| $52K-3.7% | $54K-16.9% | $65K+364% | $14K-76.7% | $60K+36.4% | ||
| $582K-67.6% | $1.8M-3.0% | $1.85M+60.9% | $1.15M-73.3% | $4.31M+9.9% | ||
| $329K— | —— | —— | —— | $0— | ||
| -$859K+50.7% | -$1.74M+2.5% | -$1.79M-57.2% | -$1.14M+73.2% | -$4.25M-9.6% | ||
| $0— | $0+100% | -$616K-508% | $151K+19.8% | $126K+216% | ||
| $27.76M+238% | $8.22M— | —— | $24.63M+53.5% | $16.04M+1,012% | ||
| $265K-45.0% | $482K+115% | $224K-71.5% | $785K+8.6% | $723K-16.9% | ||
| -$3.44M— | —— | —— | —— | $0— | ||
| -$344K— | —— | —— | —— | $0— | ||
| -$73K— | $0-100% | $29K-6.5% | $31K+3.3% | $30K+136% | ||
| -$383K-116% | $2.46M+201% | -$2.43M-162% | $3.9M+273% | -$2.25M— | ||
| —— | $11.08M0.0% | $11.08M0.0% | $11.08M0.0% | $11.08M— | ||
| —— | $418.25K0.0% | $418.25K0.0% | $418.25K0.0% | $418.25K— | ||
| $0— | $0-100% | $49.86M+308% | $12.21M-85.5% | $84.2M+17,118% | ||
| $302K+92.4% | $157K-47.1% | $297K-30.8% | $429K-19.4% | $532K+15.9% | ||
| $290K-81.5% | $1.57M— | —— | —— | $0— | ||
| $329K— | —— | —— | —— | $0— | ||
| $161K— | —— | $284K— | —— | $339K— | ||
| -$1.46M-3.0% | -$1.42M-4,191% | -$33K+57.1% | -$77K+97.2% | -$2.75M-188% | ||
| -$3K— | —— | —— | $999K-22.7% | $1.29M— | ||
| $1.32M— | $0-100% | $397K-32.9% | $592K-2.6% | $608K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$1.29M+87.3% | -$10.16M+74.7% | -$40.13M-648% | -$5.37M-87.7% | -$2.86M+54.8% | ||
| -$1.29M+87.3% | -$10.16M+74.7% | -$40.13M-648% | -$5.37M-87.7% | -$2.86M+54.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
- What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?
- After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
- Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
